The Discussion of Regulatory Inspection Key Points Based on the ProductionTechnology of Immune Cell Therapy Products
Dong Xuejiao, Guo Linfeng, Zheng Tianlei, Zhang Laijun
Chinese Pharmaceutical Affairs . 2024, (3): 245 -249 .  DOI: 10.16153/j.1002-7777.2024.03.001

京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.